Eisai Gmbh
SpainAll drugs from this manufacturer
-
It is used to treat the symptoms of mild to moderately severe Alzheimer's disease, such as memory loss, confusion, and behavioral changes.
Dosage form: tablets, film-coated
Active substance Dosage donepezil 10 mg -
It is used to treat the symptoms of mild to moderately severe Alzheimer's disease, such as memory loss, confusion, and behavioral changes.
Dosage form: tablets, film-coated
Active substance Dosage donepezil 5 mg -
It is used to treat the symptoms of mild to moderately severe Alzheimer's disease, such as memory loss, confusion, and behavioral changes.
Dosage form: tablets, buccodispersable
Active substance Dosage donepezil hydrochloride 10 mg -
It is used to treat the symptoms of mild to moderately severe Alzheimer's disease, such as memory loss, confusion, and behavioral changes.
Dosage form: tablets, buccodispersable
Active substance Dosage donepezil hydrochloride 5 mg -
It is used to treat epilepsy, with the aim of reducing the number of epileptic attacks (seizures) in adults, adolescents, and children.
Dosage form: suspension, oral
Active substance Dosage perampanel 0,5 mg/ml -
It is used to treat epilepsy, in order to reduce the number of epileptic attacks (seizures). It is used in adults, adolescents, and children to treat seizures that affect part of the brain or the entire brain.
Dosage form: tablets, film-coated
Active substance Dosage perampanel 10 mg -
It is used to treat epilepsy, specifically to reduce the number of epileptic seizures in both adults and children and adolescents, whether they are partial-onset seizures or generalized seizures.
Dosage form: tablets, film-coated
Active substance Dosage perampanel 12 mg -
It is used to reduce the number of epileptic seizures in adults, adolescents, and children, whether they are partial-onset seizures or generalized seizures.
Dosage form: tablets, film-coated
Active substance Dosage perampanel 2 mg -
It is used to treat epilepsy, with the aim of reducing the number of epileptic attacks (seizures). It is used to treat seizures that affect a part of the brain or that affect the entire brain.
Dosage form: tablets, film-coated
Active substance Dosage perampanel 4 mg -
It is used to treat epilepsy, specifically to reduce the number of epileptic seizures in both adults and children and adolescents, depending on the type of seizure.
Dosage form: tablets, film-coated
Active substance Dosage perampanel 6 mg -
It is used to reduce the number of epileptic seizures in adults, adolescents, and children, whether they are seizures that affect part of the brain or seizures that affect the whole brain.
Dosage form: tablets, film-coated
Active substance Dosage perampanel 8 mg -
It is used to treat adult patients with locally advanced or metastatic breast cancer, as well as for the treatment of adult patients with advanced or metastatic liposarcoma, provided that another treatment previously used has ceased to be effective.
Dosage form: solution for injection
Active substance Dosage eribulin mesylate 0,44 mg -
It is used to treat seizures associated with Lennox-Gastaut syndrome in adults, adolescents, and children over 1 year of age.
Dosage form: tablets, film-coated
Active substance Dosage rufinamide 100 mg -
It is used to treat seizures associated with Lennox-Gastaut syndrome in adults, adolescents, and children over 1 year of age.
Dosage form: tablets, film-coated
Active substance Dosage rufinamide 200 mg -
It is used to treat seizures associated with Lennox-Gastaut syndrome in adults, adolescents, and children over 1 year of age.
Dosage form: suspension, oral
Active substance Dosage rufinamide 40 mg -
It is used to treat seizures associated with Lennox-Gastaut syndrome in adults, adolescents, and children over 1 year of age.
Dosage form: tablets, film-coated
Active substance Dosage rufinamide 400 mg -
It is used to treat progressive or advanced thyroid cancer in adults who have not responded to radioactive iodine treatment. It is also used for liver cancer in adults who have not received prior anti-cancer therapy, or in combination with pembrolizumab for advanced endometrial (uterine) cancer.
Dosage form: capsules, hard
Active substance Dosage lenvatinib 10 mg -
It is used to treat progressive or advanced thyroid cancer in adults who have not responded to radioactive iodine treatment. It is also used to treat liver cancer (hepatocellular carcinoma) in adults who have not received any previous treatment, and in combination with pembrolizumab for advanced uterine (endometrial) cancer.
Dosage form: capsules, hard
Active substance Dosage lenvatinib 4 mg